A surge in mergers and acquisitions in March has led to high expectations for 2026. The increase in M&A activity is reportedly driven by various factors, including a rebound in the biopharma sector and a surge in fintech, although some outlets suggest the market may be split. The outlook for M&A in 2026 is uncertain, with some predicting an acceleration in startup M&A and others warning of potential inflation and interest rate impacts.